HomeNTRA • NASDAQ
add
Natera Inc
Nakaraang pagsara
$165.51
Sakop ng araw
$163.74 - $169.93
Sakop ng taon
$92.14 - $183.00
Market cap
22.36B USD
Average na Volume
1.35M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 501.83M | 36.46% |
Gastos sa pagpapatakbo | 395.94M | 39.95% |
Net na kita | -66.94M | 0.98% |
Net profit margin | -13.34 | 27.42% |
Kita sa bawat share | -0.50 | 10.71% |
EBITDA | -69.94M | -4.00% |
Aktuwal na % ng binabayarang buwis | -0.26% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 991.60M | 12.31% |
Kabuuang asset | 1.73B | 17.99% |
Kabuuang sagutin | 492.69M | -26.91% |
Kabuuang equity | 1.24B | — |
Natitirang share | 136.55M | — |
Presyo para makapag-book | 18.15 | — |
Return on assets | -11.67% | — |
Return on capital | -14.05% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -66.94M | 0.98% |
Cash mula sa mga operasyon | 44.45M | 64.63% |
Cash mula sa pag-invest | -16.82M | -112.16% |
Cash mula sa financing | 544.00K | -91.59% |
Net change in cash | 28.18M | -83.59% |
Malayang cash flow | 17.51M | 319.87% |
Tungkol
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Itinatag
Ene 1, 2004
Headquarters
Website
Mga Empleyado
4,429
